Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07874529

Cervical Cytology DNA Methylation for Endometrial Cancer Screening

Sponsor: Lei Li

View on ClinicalTrials.gov

Summary

This study intends to conduct the "Real-world Study on Cervical Cytology Methylation Testing for Endometrial Cancer Screening" project through a multi-center real-world research approach. Led by Peking Union Medical College Hospital, at least 10 institutions will participate in the study. The goal is to complete the enrollment of at least 30 million real-world samples. Focusing on the changes in DNA methylation levels in cervical exfoliated cells as the research entry point, this study aims to provide new ideas and theoretical basis for preventing and treating endometrial cancer by targeting the CDO1/CELF4 double gene methylation. The expectation is to achieve the clinical application of a more optimal endometrial cancer screening protocol, improve the current shortcomings of endometrial cancer screening, make endometrial cancer screening more accurate, effectively reduce the incidence of endometrial cancer, and avoid excessive medical treatment.

Official title: A Real-world Study on the Use of Cervical Cytology Methylation Testing for the Screening of Endometrial Cancer

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

30000

Start Date

2025-12-12

Completion Date

2027-12-01

Last Updated

2026-10-15

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

CDO1 and CELF4 gene methylation

CDO1m and CELF4m for cervical cancer screening

Locations (1)

Peking Union Medical College Hospital

Beijing, China